Graft failure

    Research output: Chapter in Book/Report/Conference proceedingChapter

    Abstract

    The failure to establish hematopoiesis after hematopoietic stem cell transplantation (HSCT) is a devastating complication that can occur during both autologous and allogeneic stem cell transplant. Early graft failure carries a poor prognosis; patients who develop late graft failure generally do slightly better. Numerous factors are known to increase the risk of engraftment failure; and working to reduce the risk upfront to minimize this tragic complication is vital, as despite improvements in supportive care the mortality associated with primary engraftment failure remains very high. In the setting of autologous stem cell transplant, newer agents to enhance mobilization of stem cells and recognition of clear minimum stem cell doses required to proceed with the procedure have minimized the risks of graft failure as best as possible.

    Original languageEnglish (US)
    Title of host publicationBlood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care
    PublisherSpringer New York
    Pages265-270
    Number of pages6
    ISBN (Print)9781441975058
    DOIs
    StatePublished - 2011

    Fingerprint

    Transplants
    Stem Cells
    Hematopoietic Stem Cell Mobilization
    Hematopoietic Stem Cell Transplantation
    Hematopoiesis
    Mortality

    ASJC Scopus subject areas

    • Medicine(all)

    Cite this

    Meyers, G. (2011). Graft failure. In Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care (pp. 265-270). Springer New York. https://doi.org/10.1007/978-1-4419-7506-5_23

    Graft failure. / Meyers, Gabrielle.

    Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care. Springer New York, 2011. p. 265-270.

    Research output: Chapter in Book/Report/Conference proceedingChapter

    Meyers, G 2011, Graft failure. in Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care. Springer New York, pp. 265-270. https://doi.org/10.1007/978-1-4419-7506-5_23
    Meyers G. Graft failure. In Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care. Springer New York. 2011. p. 265-270 https://doi.org/10.1007/978-1-4419-7506-5_23
    Meyers, Gabrielle. / Graft failure. Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care. Springer New York, 2011. pp. 265-270
    @inbook{8d0d0dbe47e7463ea82ccdc5cf1252d9,
    title = "Graft failure",
    abstract = "The failure to establish hematopoiesis after hematopoietic stem cell transplantation (HSCT) is a devastating complication that can occur during both autologous and allogeneic stem cell transplant. Early graft failure carries a poor prognosis; patients who develop late graft failure generally do slightly better. Numerous factors are known to increase the risk of engraftment failure; and working to reduce the risk upfront to minimize this tragic complication is vital, as despite improvements in supportive care the mortality associated with primary engraftment failure remains very high. In the setting of autologous stem cell transplant, newer agents to enhance mobilization of stem cells and recognition of clear minimum stem cell doses required to proceed with the procedure have minimized the risks of graft failure as best as possible.",
    author = "Gabrielle Meyers",
    year = "2011",
    doi = "10.1007/978-1-4419-7506-5_23",
    language = "English (US)",
    isbn = "9781441975058",
    pages = "265--270",
    booktitle = "Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care",
    publisher = "Springer New York",

    }

    TY - CHAP

    T1 - Graft failure

    AU - Meyers, Gabrielle

    PY - 2011

    Y1 - 2011

    N2 - The failure to establish hematopoiesis after hematopoietic stem cell transplantation (HSCT) is a devastating complication that can occur during both autologous and allogeneic stem cell transplant. Early graft failure carries a poor prognosis; patients who develop late graft failure generally do slightly better. Numerous factors are known to increase the risk of engraftment failure; and working to reduce the risk upfront to minimize this tragic complication is vital, as despite improvements in supportive care the mortality associated with primary engraftment failure remains very high. In the setting of autologous stem cell transplant, newer agents to enhance mobilization of stem cells and recognition of clear minimum stem cell doses required to proceed with the procedure have minimized the risks of graft failure as best as possible.

    AB - The failure to establish hematopoiesis after hematopoietic stem cell transplantation (HSCT) is a devastating complication that can occur during both autologous and allogeneic stem cell transplant. Early graft failure carries a poor prognosis; patients who develop late graft failure generally do slightly better. Numerous factors are known to increase the risk of engraftment failure; and working to reduce the risk upfront to minimize this tragic complication is vital, as despite improvements in supportive care the mortality associated with primary engraftment failure remains very high. In the setting of autologous stem cell transplant, newer agents to enhance mobilization of stem cells and recognition of clear minimum stem cell doses required to proceed with the procedure have minimized the risks of graft failure as best as possible.

    UR - http://www.scopus.com/inward/record.url?scp=84892304219&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84892304219&partnerID=8YFLogxK

    U2 - 10.1007/978-1-4419-7506-5_23

    DO - 10.1007/978-1-4419-7506-5_23

    M3 - Chapter

    SN - 9781441975058

    SP - 265

    EP - 270

    BT - Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care

    PB - Springer New York

    ER -